Location History:
- New Rochelle, NY (US) (2018)
- New York, NY (US) (2018)
Company Filing History:
2 out of 1,697 
1 out of 2,886 
1 out of 560 
Years Active: 2018
Title: Innovations and Contributions of Inventor Randy S Longman
Introduction
Randy S Longman is a notable inventor based in New Rochelle, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory bowel disease and rheumatoid arthritis. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Randy S Longman's latest patents include innovative methods for treating inflammatory bowel disease. One patent focuses on administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody. This method aims to promote mucosal healing in the gastrointestinal (GI) tract by activating mononuclear phagocytes (MNPs) and regulating interleukin (IL)-22-producing group 3 innate lymphoid cells (ILC3). Another patent addresses rheumatoid arthritis, detailing methods, reagents, and compositions for predicting RA onset in susceptible individuals. This includes diagnostic methods for evaluating the efficacy of therapeutic regimens and identifying specific bacterial species as biomarkers.
Career Highlights
Throughout his career, Randy has worked with prestigious institutions such as New York University and Cornell University. His research has contributed to advancements in understanding and treating complex diseases, showcasing his dedication to improving patient outcomes.
Collaborations
Randy has collaborated with esteemed colleagues, including Dan R Littman and Gretchen E Diehl. These partnerships have further enriched his research and expanded the impact of his innovations.
Conclusion
Randy S Longman is a distinguished inventor whose work in medical research has led to valuable patents and collaborations. His contributions continue to pave the way for advancements in the treatment of inflammatory bowel disease and rheumatoid arthritis.